ACT-335827 is a selective, orally active, brain-penetrant orexin type 1 receptor antagonist. ACT-33582 acts on OXR1 and OXR2 with IC50 values of 6 nM and 417 nM, respectively. ACT-33582 can be used in studies related to neurological disorders[1].
Molecular Weight:
518.64
Purity:
98
CAS Number:
[1354039-86-3]
Formula:
C31H38N2O5
Target:
Orexin Receptor (OX Receptor)
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted